{"id":"W2125643269","doi":"10.1023/a:1008382516636","title":"Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse","year":2001,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":372,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"University of California, San Francisco","keywords":"Medicine; Temozolomide; Internal medicine; Clinical endpoint; Phases of clinical research; Chemotherapy; Lomustine; Population; Progression-free survival; Surgery; Oncology; Gliosarcoma; Progressive disease; Clinical trial; Glioblastoma; Vincristine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001471877,0.0001448685,0.0005863145,0.0002108804,0.00003957311,0.000001199354,0.00006443865,0.0001300792,0.0001617644],"category_scores_gemma":[0.0001438333,0.0001031635,0.0001079635,0.0001853908,0.0001128079,0.00005813922,0.00006341076,0.00008253205,0.00001404618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008993212,"about_ca_system_score_gemma":0.00005479901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001058813,"about_ca_topic_score_gemma":0.0008038486,"domain_scores_codex":[0.9987753,0.00004431409,0.0005048442,0.0002112047,0.0001992452,0.0002650818],"domain_scores_gemma":[0.9989944,0.000160981,0.0002919335,0.0002479048,0.0001952658,0.0001095743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4229225,0.05148358,0.4871779,0.0000527011,0.000276523,0.0002974141,0.0005580203,0.00001691571,0.0004000746,0.0000142127,0.003189295,0.0336109],"study_design_scores_gemma":[0.5537767,0.1797295,0.218423,0.000219175,0.0001519546,0.00001417244,0.00006262675,0.00006505653,0.01510994,0.000008659194,0.03229403,0.0001451469],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959501,0.00006666756,5.417574e-7,0.002051442,0.0001125151,0.0009551335,0.00002634062,0.000009423446,0.0008278402],"genre_scores_gemma":[0.9992294,0.0001186677,0.0001505745,0.0002826225,0.00003423993,0.0000628567,0.00003293413,0.0000147267,0.0000739336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2687549,"threshold_uncertainty_score":0.4206884,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03575505135581412,"score_gpt":0.3477511933093104,"score_spread":0.3119961419534962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}